Noninvasive |
|
0 | No evidence of cancer cells or invasion of the basement membrane of the duct or neighbouring normal tissue; includes ductal carcinoma in situ |
|
Invasive |
|
IA |
|
|
IB |
No tumour in the breast, but microscopic metastases (> 0.2 mm but ≤ 2 mm) present in axillary lymph nodes OR Tumour present in the breast, ≤ 2 cm, with involvement of lymph nodes
|
|
IIA |
No tumour in the breast, but macroscopic cancer (> 2 mm) in 1–3 axillary lymph nodes OR Tumour ≤ 2 cm, with spread to axillary lymph nodes OR Tumour > 2 cm but ≤ 5 cm, with no spread to axillary lymph nodes
|
|
IIB |
Tumour > 2 cm but ≤ 5 cm, with spread to 1–3 axillary lymph nodes OR Tumour > 5 cm, with no spread to axillary lymph nodes
|
|
IIIA |
No tumour in the breast or presence of a breast tumour of any size associated with metastases in 4–9 axillary lymph nodes or in internal mammary nodes OR Tumour > 5 cm, with spread to axillary and/or internal mammary nodes
|
|
IIIB |
|
|
IIIC |
Tumour of any size, with spread to ≥ 10 axillary lymph nodes OR Spread to lymph nodes above or below the collarbone (supraclavicular nodes) OR Spread to both axillary lymph nodes and internal mammary nodes
|
|
Metastatic |
IV | Spread of cancer to other parts of the body such as liver, lung or bone |